first approval for ceftobiprole medocaril in europe
Post on 12-Dec-2016
213 views
TRANSCRIPT
Inpharma 1665 - 22 Nov 2008
■ First approval for ceftobiprole medocaril inEurope. Swissmedic has approved ceftobiprolemedocaril [Zevtera] as a treatment for complicatedskin and skin structure infections, including diabeticfoot infections that have not spread to the bone.Basilea Pharmaceutica and Janssen-Cilag will marketthis antibacterial product in Switzerland. The use ofceftobiprole for this indication is under regulatoryreview in the US, Australia, and the EU, among othercountries; ceftobiprole [as Zeftera] was launched inCanada in August 2008.Janssen-Cilag. New Antibiotic Against Serious Infections - Receives FirstApproval in Europe. Media Release : 13 Nov 2008. Available from: URL:http://www.janssen-cilag.com 809095370
1
Inpharma 22 Nov 2008 No. 16651173-8324/10/1665-0001/$14.95 Adis © 2010 Springer International Publishing AG. All rights reserved